Home › A.P. Pharma Receives FDA Complete Response Letter For APF530
 

Keywords :   


A.P. Pharma Receives FDA Complete Response Letter For APF530

2013-03-28 08:00:00| dairynetwork Home Page

A.P. Pharma, Inc., a specialty pharmaceutical company, recently announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).

Tags: complete response letter receives

Category:Agriculture and Forestry

Latest from this category

All news
27.11Washington Corner | November 2024
27.11Pork Checkoff continues building a bigger appetite for pork
27.11Terminal crossbreeding: A missed opportunity
27.11Feedlot Forum 2025 features Cattle feeding in a changing environment
27.11Smithfield Foods continues support for Mayflower Marathon Holiday Food Drive
27.11Researchers turn to AI to optimize hog selling
27.11H5N1 in pigs: Where are the knowledge gaps?
26.11New swine respiratory disease treatment flexibility from nursery to finish
Agriculture and Forestry »
27.11
27.11240
27.11 C.J.Date
27.11VR7001
27.11BEAST
27.11
27.11
27.11 112
More »